Paragon Associates & Paragon Associates Ii Joint Venture Care Dx, Inc. Transaction History

Paragon Associates & Paragon Associates Ii Joint Venture

$56.1 Million
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$20.03 - $40.08 $500,750 - $1 Million	-25,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$25.78 - $39.77 $644,500 - $994,250	-25,000 Reduced 50.0%	25,000 $900,000
Q1 2019 May 14, 2019	SELL	$22.09 - $39.21 $1.1 Million - $1.96 Million	-50,000 Reduced 50.0%	50,000 $1.58 Million
Q4 2018 Feb 13, 2019	SELL	$19.89 - $30.02 $994,500 - $1.5 Million	-50,000 Reduced 33.33%	100,000 $2.51 Million
Q3 2018 Nov 14, 2018	SELL	$12.1 - $28.85 $2.24 Million - $5.34 Million	-185,000 Reduced 55.22%	150,000 $4.33 Million

Q2 2018 Aug 14, 2018	SELL	$7.93 - $15.79 $1.82 Million - $3.63 Million	-229,600 Reduced 40.67%	335,000 $4.1 Million
Q1 2018 May 15, 2018	SELL	$5.18 - $7.97 $1.99 Million - $3.06 Million	-383,400 Reduced 40.44%	564,600 $4.5 Million
Q4 2017 Feb 13, 2018	SELL	$3.98 - $7.37 $1.3 Million - $2.4 Million	-325,800 Reduced 25.58%	948,000 $6.96 Million
Q3 2017 Nov 13, 2017	BUY	$1.33 - $4.12 $1.69 Million - $5.25 Million	1,273,800	1,273,800 $4.71 Million

Others Institutions Holding CDNA

# of Institutions

150

Shares Held

55.1M

Call Options Held

85.8K

Put Options Held

48.8K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.86M
Shares

$91.1 Million
0.44% of portfolio
Black Rock Inc. New York, NY

5.43M
Shares

$84.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.3M
Shares

$66.8 Million
0.0% of portfolio
State Street Corp Boston, MA

4.2M
Shares

$65.2 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.93M
Shares

$61.1 Million
0.65% of portfolio

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $830M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Associates & Paragon Associates Ii Joint Venture, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Associates & Paragon Associates Ii Joint Venture with notifications on news.

Account